Royal Bank Of Canada Amphastar Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

  • $528 Billion
  • Q2 2025

A detailed history of Royal Bank Of Canada transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 318,717 shares of AMPH stock, worth $9.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
318,717
Previous 26,079 1122.12%
Holding current value
$9.67 Million
Previous $756,000 867.86%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$22.96 - $28.29 $6.72 Million - $8.28 Million
292,638 Added 1122.12%
318,717 $7.32 Million
Q1 2025

May 15, 2025
SELL
$26.24 - $38.48 $66,990 - $98,239
-2,553 Reduced 8.92%
26,079 $756,000
Q4 2024

Feb 14, 2025
BUY
$36.84 - $53.4 $78,027 - $113,101
2,118 Added 7.99%
28,632 $1.06 Million
Q3 2024

Nov 14, 2024
SELL
$36.99 - $50.09 $246,723 - $334,100
-6,670 Reduced 20.1%
26,514 $1.29 Million
Q2 2024

Aug 14, 2024
BUY
$38.65 - $43.48 $813,389 - $915,036
21,045 Added 173.37%
33,184 $1.33 Million
Q1 2024

Nov 05, 2024
SELL
$42.85 - $63.45 $901,778 - $1.34 Million
-21,045 Reduced 63.42%
12,139 $533,000
Q1 2024

May 15, 2024
SELL
$42.85 - $63.45 $1.89 Million - $2.8 Million
-44,162 Reduced 78.44%
12,139 $533,000
Q4 2023

Feb 14, 2024
BUY
$44.49 - $62.93 $2.25 Million - $3.18 Million
50,512 Added 872.55%
56,301 $3.48 Million
Q3 2023

Nov 14, 2023
SELL
$45.51 - $65.0 $894,726 - $1.28 Million
-19,660 Reduced 77.25%
5,789 $266,000
Q2 2023

Aug 14, 2023
BUY
$35.77 - $58.38 $767,624 - $1.25 Million
21,460 Added 537.98%
25,449 $1.46 Million
Q1 2023

May 15, 2023
SELL
$27.99 - $37.92 $133,708 - $181,143
-4,777 Reduced 54.49%
3,989 $149,000
Q4 2022

Feb 14, 2023
BUY
$27.93 - $31.27 $132,807 - $148,688
4,755 Added 118.55%
8,766 $245,000
Q3 2022

Nov 14, 2022
BUY
$27.56 - $37.75 $17,748 - $24,311
644 Added 19.13%
4,011 $112,000
Q2 2022

Aug 15, 2022
SELL
$29.79 - $42.29 $691,664 - $981,889
-23,218 Reduced 87.33%
3,367 $117,000
Q1 2022

May 16, 2022
BUY
$22.96 - $36.45 $439,500 - $697,725
19,142 Added 257.18%
26,585 $954,000
Q4 2021

Feb 14, 2022
BUY
$18.14 - $23.29 $52,950 - $67,983
2,919 Added 64.52%
7,443 $174,000
Q3 2021

Nov 15, 2021
BUY
$17.83 - $21.49 $17,651 - $21,275
990 Added 28.01%
4,524 $87,000
Q2 2021

Aug 16, 2021
BUY
$17.11 - $20.92 $60,466 - $73,931
3,534 New
3,534 $71,000

Others Institutions Holding AMPH

# of Institutions
257
Shares Held
32.9M
Call Options Held
18.3K
Put Options Held
12.6K
View Full List

About Amphastar Pharmaceuticals, Inc.

AMPH Quotes by TradingView
  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.49B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email